Cargando…

Prognostic impact of the post-treatment T cell composition and spatial organization in soft tissue sarcoma patients treated with neoadjuvant hyperthermic radio(chemo)therapy

Soft tissue sarcomas (STS) form a heterogeneous group of tumors sharing a mesenchymal origin. Despite good local control of the disease, the occurrence of distant metastases often limits survival of STS patients with localized, high-risk tumors of the extremities. Accumulating evidence suggests a ce...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rupp, Luise, Resag, Antonia, Potkrajcic, Vlatko, Warm, Verena, Wehner, Rebekka, Jöhrens, Korinna, Bösmüller, Hans, Eckert, Franziska, Schmitz, Marc
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10228739/ https://www.ncbi.nlm.nih.gov/pubmed/37261361 http://dx.doi.org/10.3389/fimmu.2023.1185197

Ejemplares similares

The Immune Contexture of Liposarcoma and Its Clinical Implications
por: Resag, Antonia, et al.
Publicado: (2022)

Dose-escalated Radiotherapy with Simultaneous Integrated Boost for Bone Metastases in Selected Patients with Assumed Favourable Prognosis
por: Potkrajcic, Vlatko, et al.
Publicado: (2022)

Hypofractionated Preoperative Radiotherapy for High Risk Soft Tissue Sarcomas in a Geriatric Patient Population
por: Potkrajcic, Vlatko, et al.
Publicado: (2021)

MR Thermometry Data Correlate with Pathological Response for Soft Tissue Sarcoma of the Lower Extremity in a Single Center Analysis of Prospectively Registered Patients
por: Unsoeld, Michaela, et al.
Publicado: (2020)

Postoperative complications and oncologic outcomes after multimodal therapy of localized high risk soft tissue sarcoma
por: Potkrajcic, Vlatko, et al.
Publicado: (2022)

Step-by-Step Design of New Theranostic Nanoformulations: Multifunctional Nanovectors for Radio-Chemo-Hyperthermic Therapy under Physical Targeting
por: Ansari, Shoeb Anwar, et al.
Publicado: (2021)

Pathologic Assessment of Rectal Carcinoma after Neoadjuvant Radio(chemo)therapy: Prognostic Implications
por: Hav, Monirath, et al.
Publicado: (2015)

Association of mismatch repair status with survival and response to neoadjuvant chemo(radio)therapy in rectal cancer
por: Ye, Shu-Biao, et al.
Publicado: (2020)

Clinical outcome of elderly patients (≥ 70 years) with esophageal cancer undergoing definitive or neoadjuvant radio(chemo)therapy: a retrospective single center analysis
por: Walter, Franziska, et al.
Publicado: (2018)

Subjective voice quality, communicative ability and swallowing after definitive radio(chemo)therapy, laryngectomy plus radio(chemo)therapy, or organ conservation surgery plus radio(chemo)therapy for laryngeal and hypopharyngeal cancer
por: Szuecs, Marcella, et al.
Publicado: (2015)

The Challenge to the Pathologist of PD-L1 Expression in Tumor Cells of Non-Small-Cell Lung Cancer—An Overview
por: Jöhrens, Korinna, et al.
Publicado: (2021)

The roles of glucose metabolic reprogramming in chemo- and radio-resistance
por: Lin, Jinguan, et al.
Publicado: (2019)

Associations of chemo- and radio-resistant phenotypes with the gap junction, adhesion and extracellular matrix in a three-dimensional culture model of soft sarcoma
por: Bai, Chujie, et al.
Publicado: (2015)

Expression Pattern and Prognostic Value of CTLA-4, CD86, and Tumor-Infiltrating Lymphocytes in Rectal Cancer after Neoadjuvant Chemo(radio)therapy
por: Yin, Xin-Ke, et al.
Publicado: (2022)

Photodynamic hyperthermal chemotherapy with indocyanine green in feline vaccine-associated sarcoma
por: ONOYAMA, MASAKI, et al.
Publicado: (2015)

Longitudinal atherosclerotic changes after radio(chemo)therapy of hypopharyngeal carcinoma
por: Simonetto, Cristoforo, et al.
Publicado: (2020)

Radio(chemo)therapy in locally advanced nonsmall cell lung cancer
por: Glatzer, Markus, et al.
Publicado: (2016)

Preoperative Radio(Chemo)Therapy in Breast Cancer: Time to Switch the Perspective?
por: Montero, Angel, et al.
Publicado: (2022)

A case series in patients with enteropathy and granulomatous diseases
por: Kruis, Tassilo, et al.
Publicado: (2015)

The rationale for including immune checkpoint inhibition into multimodal primary treatment concepts of head and neck cancer
por: Tinhofer, Ingeborg, et al.
Publicado: (2016)

Favorable therapeutic response after anti-Mesothelin antibody–drug conjugate treatment requires high expression of Mesothelin in tumor cells
por: Lazzerini, Lea, et al.
Publicado: (2020)

Is consolidative thoracic radiotherapy of extensive-stage small cell lung cancer still beneficial in the era of immunotherapy? A retrospective analysis
por: Hoffmann, Elgin, et al.
Publicado: (2023)

Survival benefits of neoadjuvant chemo(radio)therapy versus surgery first in patients with resectable or borderline resectable pancreatic cancer: a systematic review and meta-analysis
por: Pan, Long, et al.
Publicado: (2019)

Effect of neoadjuvant chemotherapy combined with hyperthermic intraperitoneal perfusion chemotherapy on advanced gastric cancer
por: CUI, HAI-BIN, et al.
Publicado: (2014)

Overcoming chemo/radio-resistance of pancreatic cancer by inhibiting STAT3 signaling
por: Wu, Xiaoqing, et al.
Publicado: (2016)

Overestimation of grey matter atrophy in glioblastoma patients following radio(chemo)therapy
por: Gommlich, A., et al.
Publicado: (2021)

Commentary: Immuno-chemo-radio-therapy before esophagectomy: Our next standard?
por: Ripley, R. Taylor
Publicado: (2022)

Pazopanib radio-sensitization of human sarcoma tumors
por: Wang, Feng, et al.
Publicado: (2018)

Influence of Interferon-Alpha Combined with Chemo (Radio) Therapy on Immunological Parameters in Pancreatic Adenocarcinoma
por: Karakhanova, Svetlana, et al.
Publicado: (2014)

Stent patency in patients with distal malignant biliary obstruction receiving chemo(radio)therapy
por: Haal, Sylke, et al.
Publicado: (2017)

Monomethyl auristatin antibody and peptide drug conjugates for trimodal cancer chemo-radio-immunotherapy
por: Hingorani, Dina V., et al.
Publicado: (2022)

Editorial: Combining chemo/radio therapy and immunotherapy for cancers—perfect mix of old and new
por: Slaney, Clare Y., et al.
Publicado: (2023)

Relevance of the time interval between surgery and adjuvant radio (chemo) therapy in HPV-negative and advanced head and neck carcinoma of unknown primary (CUP)
por: Balk, Matthias, et al.
Publicado: (2021)

Neoadjuvant chemo-immunotherapy for lung cancer: how much is too much?
por: Deboever, Nathaniel, et al.
Publicado: (2022)

CD133 expression in chemo-resistant Ewing sarcoma cells
por: Jiang, Xiaohua, et al.
Publicado: (2010)

Hyperthermal Medication
por: De Sandfort, Barthe
Publicado: (1910)

Toxicity and morbility after isolated lower limb perfusion in 242 chemo-hyperthermal treatments for cutaneous melanoma: The experience of the Tuscan Reference Centre
por: Pace, Marcello, et al.
Publicado: (2008)

Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in seven patients with peritoneal sarcomatosis from uterine sarcoma
por: Sardi, Armando, et al.
Publicado: (2018)

Increase of T and B cells and altered BACH2 expression patterns in bone marrow trephines of imatinib-treated patients with chronic myelogenous leukaemia
por: Von Laffert, Maximilian, et al.
Publicado: (2016)

Possible Estrogen Dependency in the Pathogenesis of Branchial Cleft Cysts
por: Raguse, Jan D., et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_idsruvr2g22u04pq3402s26p77